Trials / Unknown
UnknownNCT02990403
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Shanghai First Maternity and Infant Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
In this clinical cohort study, the investigators are going to observe the efficacy of anti-coagulation and immune therapy in the treatment of recurrent pregnancy loss with a prospective randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | |
| DRUG | Heparin | |
| DRUG | Prednisone | |
| DRUG | Immunoglobulin | |
| DRUG | Dydrogesterone |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2017-06-10
- Completion
- 2018-12-22
- First posted
- 2016-12-13
- Last updated
- 2017-03-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02990403. Inclusion in this directory is not an endorsement.